Patient Outcomes by Ventricular Systolic and Diastolic Function.

death diastolic dysfunction ejection fraction hospitalization myocardial function

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
14 Feb 2024
Historique:
medline: 14 2 2024
pubmed: 14 2 2024
entrez: 14 2 2024
Statut: aheadofprint

Résumé

Left ventricular dysfunction is characterized by systolic and diastolic parameters, leading to heart failure (HF) with reduced or preserved ejection fraction (EF), respectively. The goal of this study is to examine the impact of left ventricular systolic and diastolic dysfunction (DD) on patient outcomes. Two cohorts were used in this analysis: Cohort A included 136 455 patients with EF ≥50%, stratified by the presence and grade of DD. Cohort B included 16 850 patients with EF <50%, stratified by EF quartiles. Patients were followed to the end points of all-cause death and cardiovascular, HF, or cardiac arrest hospitalizations. Over a median follow-up of 3.42 years, 23 946 (16%) patients died and 31 113 (20%), 13 305 (9%), and 1269 (1%) were hospitalized for cardiovascular, HF, or cardiac arrest causes, respectively. With adjustment for comorbidities, the risk of all-cause mortality and of cardiovascular and HF hospitalizations increased steadily with increasing grade of DD in patients with normal EF, and even more so in patients with worsening EF. The risk of hospitalization for cardiac arrest in patients with grade III DD, however, was comparable to that of patients with EF <25% (hazard ratio, 1.00 [95% CI, 0.98-1.01]) and worse than that of patients in better EF quartiles. Although systolic dysfunction is associated with a greater risk of overall death and HF hospitalizations than DD, the risk of cardiac arrest in patients with grade II and III DD is comparable to that of patients with moderate and severe systolic dysfunction, respectively. Future studies are needed to examine treatment strategies than can improve these outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Left ventricular dysfunction is characterized by systolic and diastolic parameters, leading to heart failure (HF) with reduced or preserved ejection fraction (EF), respectively. The goal of this study is to examine the impact of left ventricular systolic and diastolic dysfunction (DD) on patient outcomes.
METHODS AND RESULTS RESULTS
Two cohorts were used in this analysis: Cohort A included 136 455 patients with EF ≥50%, stratified by the presence and grade of DD. Cohort B included 16 850 patients with EF <50%, stratified by EF quartiles. Patients were followed to the end points of all-cause death and cardiovascular, HF, or cardiac arrest hospitalizations. Over a median follow-up of 3.42 years, 23 946 (16%) patients died and 31 113 (20%), 13 305 (9%), and 1269 (1%) were hospitalized for cardiovascular, HF, or cardiac arrest causes, respectively. With adjustment for comorbidities, the risk of all-cause mortality and of cardiovascular and HF hospitalizations increased steadily with increasing grade of DD in patients with normal EF, and even more so in patients with worsening EF. The risk of hospitalization for cardiac arrest in patients with grade III DD, however, was comparable to that of patients with EF <25% (hazard ratio, 1.00 [95% CI, 0.98-1.01]) and worse than that of patients in better EF quartiles.
CONCLUSIONS CONCLUSIONS
Although systolic dysfunction is associated with a greater risk of overall death and HF hospitalizations than DD, the risk of cardiac arrest in patients with grade II and III DD is comparable to that of patients with moderate and severe systolic dysfunction, respectively. Future studies are needed to examine treatment strategies than can improve these outcomes.

Identifiants

pubmed: 38353214
doi: 10.1161/JAHA.123.033211
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033211

Auteurs

Jacqueline Levene (J)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Andrew Voigt (A)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Floyd Thoma (F)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Suresh Mulukutla (S)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Aditya Bhonsale (A)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Krishna Kancharla (K)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Alaa Shalaby (A)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

N A Mark Estes (NAM)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Sandeep Jain (S)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Samir Saba (S)

Heart and Vascular Institute at the University of Pittsburgh School of Medicine Pittsburgh PA USA.

Classifications MeSH